Drugs & Therapy Perspectives

, Volume 15, Issue 2, pp 14–16 | Cite as

Visual field defects with vigabatrin: an unforeseen problem?

Drug reactions and interactions


Visual Field Vigabatrin Visual Field Defect Infantile Spasm Visual Abnormality 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Eke T, Talbot JF, Lawden MC. Severe persistent visual field constriction associated with vigabatrin. BMJ 1997 Jan 18; 314: 180–1PubMedCrossRefGoogle Scholar
  2. 2.
    British National Formulary. No. 38. London: The Pharmaceutical Press, 1999 Sep: 222-3Google Scholar
  3. 3.
    Innes C. All eyes on the pros and cons of vigabatrin. Inpharma 1999 Oct 9; 1208: 20–1CrossRefGoogle Scholar
  4. 4.
    Gross-Tsur V, Shalev RS, Shahar E. Ophthalmological abnormalities in children with epilepsy treated with vigabatrin. Ann Neurol 1999 Sep; 46: 524–5Google Scholar
  5. 5.
    Vanhatalo S, Pääkkönen L. Visual field constriction in children treated with vigabatrin. Neurology 1999; 52: 1713–4PubMedCrossRefGoogle Scholar
  6. 6.
    Sankar R, Wasterlain CG. Is the devil we know the lesser of two evils? Vigabatrin and visual fields. Neurology 1999 May 12; 52: 1537–8PubMedCrossRefGoogle Scholar
  7. 7.
    Update on visual field constriction with vigabatrin. Aust Adv Drug React Bull 1999 Feb; 18: 3Google Scholar
  8. 8.
    Vigabatrin (Sabril) and visual field defects. Curr Probi Pharmacovigilance 1998 Mar; 24: 1Google Scholar
  9. 9.
    Arndt CF, Derambure P, Defoort-Dhellemmes S, et al. Outer retinal dysfunction in patients treated with vigabatrin. Neurology 1999 Apr 12; 52: 1201–5PubMedCrossRefGoogle Scholar
  10. 10.
    Schmidt T, Schmitz B, Jokiel B. Constriction of the visual field in epilepsy patients taking vigabatrin and other antiepileptic drugs. Epilepsia 1999 Jan; 40(Suppl. 2): 256, 1999Google Scholar
  11. 11.
    Lawden MC, Eke T, Degg C. Visual field constriction associated with vigabatrin treatment. Epilepsia 1999 Jan; 40(Suppl. 2): 256–257 (plus poster), 1999Google Scholar
  12. 12.
    Zamponi N, Tavoni MA, Porfiri L, et al. Visual field defects associated with vigabatrin (VGB) monotherapy in asymptomatic children: preliminary results. Epilepsia 1999 Jan; 40(Suppl. 2): 70, 1999Google Scholar
  13. 13.
    Versino M, Veggiotti P. Reversibility of vigabatrin-induced visual-field defect. Lancet 1999 Aug 7; 354: 486PubMedCrossRefGoogle Scholar
  14. 14.
    Paul SR, Krauss GL, Johnson MA, et al. Progression and recovery of visual function in patients treated with vigabatrin. Epilepsia 1999 Jan; 40(Suppl. 2): 287–288, 1999Google Scholar

Copyright information

© Adis International Limited 2000

Personalised recommendations